Live Breaking News & Updates on Israeli Digital Health First Vc Firm

December 21, 2020
December 21, 2020 | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more.
$170M: Israeli ‘Digital Health First’ VC Firm
OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value of $170M. OTV also announced their new name and the appointment of a new Head of Asia Pacific to spearhead the fund’s expansion into the region’s market. OTV is the only venture capital fund in Israel whose primary focus is digital health, specializing in supporting their portfolio companies reach maturity, refine execution, tackle regulatory hurdles and ensure a global imprint on validated products. Over the course of the past five years, OTV has prioritized investment in di ....

United States , Argyll And Bute , United Kingdom , Ulf Landegren , Jonathan Tisch , Sujit Nair , Robert Valenzuela , John Shoffner , Jasont Gammack , Asia Pacific , Andreessen Horowitz , David Shaw , Avinash Reddy , Oncolytic Immunotherapies , Intervenn Biosciences , Sherlock Biosciences , Carl Henric Svanberg , Andreas Ehn , Steven Kaplan , Kevin Love , Michael Palese , Intuitive Investments Group , Seegene Medical Foundation , Israeli Digital Health First Vc Firm , Brainbox Solutions , United Kingdom Investment Firm For Life Sciences ,